Analyst firms · Argus Research · HUM

Argus Research HUM price target and rating history

Humana Inc. (HUM) · Health Care

Argus Research rates Humana Inc. (HUM) Hold with a $550 price target, as of its latest action on Mar 13, 2024. It has published 3 rating actions on HUM since June 2023, including 1 upgrade and 2 downgrades. Across 12 firms with a HUM price target in the last 12 months, the median target is $501.

Current rating
Hold
Price target
$550
Median target, all firms
$501
Actions on HUM
3

Every Argus Research rating on HUM

How other firms rate HUM

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
RBC Capital MarketsOutperform$563Nov 16, 2026
Raymond JamesOutperform$520Oct 12, 2026
Robert W. BairdOutperform$596Oct 9, 2026
Cantor FitzgeraldOverweight$460Oct 7, 2026
BarclaysOverweight$515Sep 25, 2026
Morgan StanleyEqual-Weight$370Aug 5, 2026
Evercore ISIOutperform$480Jul 30, 2026
Leerink PartnersOutperform$513Jul 30, 2026
BofA SecuritiesBuy$500Jul 29, 2026
Wells FargoOverweight$502Jul 13, 2026
Deutsche BankBuy$441May 20, 2026
JefferiesBuy$313Dec 5, 2025

Questions about Argus Research and HUM

What is Argus Research's price target for HUM?
Argus Research's latest stated price target for Humana Inc. (HUM) is $550, from its action on Dec 12, 2023.
What is Argus Research's rating on HUM?
Argus Research rates HUM Hold, a neutral rating, as of Mar 13, 2024.
When did Argus Research last change its view on HUM?
On Mar 13, 2024, Argus Research downgrades to Hold from Buy.
How does Argus Research's HUM target compare with other analysts?
Across 12 firms with a HUM price target in the last 12 months, the median target is $501.

More HUM rating histories

All Argus Research ratingsHUM news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.